Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

Oramed Is Now The First To Show Evidence

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
trendmkr Member Profile
 
Followed By 12
Posts 911
Boards Moderated 0
Alias Born 05/29/15
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 7:04:56 AM
Oramed Announces Successful Phase IIb Study of Oral Insulin in Type 2 Diabetes PR Newswire (US) - 11/12/2019 7:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 10/23/2019 4:36:39 PM
Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference PR Newswire (US) - 9/18/2019 8:38:00 AM
Oramed Announces Last Patient Treated in Pivotal Phase IIb Trial of Oral Insulin ORMD-0801 PR Newswire (US) - 9/17/2019 8:40:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:09:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:08:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:07:48 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/16/2019 6:07:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:07:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:06:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:18:02 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/5/2019 4:49:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/5/2019 4:42:36 PM
Oramed to Present at Three Upcoming Conferences PR Newswire (US) - 9/3/2019 8:25:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/21/2019 5:28:25 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/6/2019 1:29:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2019 6:08:14 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/19/2019 12:12:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/18/2019 1:32:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/15/2019 7:03:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/10/2019 5:28:14 PM
Oramed to Present at World Diabetes Congress PR Newswire (US) - 7/10/2019 8:40:00 AM
Oramed Announces Xiaoming Gao Joins Board of Directors PR Newswire (US) - 7/2/2019 8:25:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/1/2019 3:18:58 PM
trendmkr   Wednesday, 12/14/16 11:23:49 PM
Re: None
Post # of 520 
Oramed Is Now The First To Show Evidence That Insulin Can Be Taken Orally

Mayer Winkler

Summary

Injectable insulin has been around since 1923, but oral insulin has proven elusive to date.
Oramed Pharmaceuticals' successful Phase IIB trial for oral insulin has shown that it can be done.

The potential advantage of oral insulin is beyond the issue of convenience, as oral administration delivers insulin directly to the liver which regulates its release naturally.

This would obviate the need to chemically alter insulin in order to regulate its release molecularly.
Oramed has plenty of cash and about a 5 year runway at current burn rate.

More than 400 million individuals suffer from diabetes, or about 5.5% of the world's population. One in every five dollars spent on healthcare in the US goes towards diabetes treatment. It's reached epidemic levels as global sugar intake increases, and its incidence rate keeps going up. It's also an area in which treatment options are not only limited, but terribly outdated.

Injectable insulin, which is far and away the most widely used treatment for both diabetes type I and II, has been widely available since 1923. One serious issue with injectable insulin is not that it doesn't work, but that it cannot be naturally regulated by the human body. Insulin directly to the blood needs to be regulated by the user in combination with various technological release modulators that chemically alter the insulin in order to make it either fast or slow-acting, depending on the user's choice. In healthy non-diabetics by contrast, insulin is delivered through the portal vein directly to the liver, which regulates its release and activation naturally.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist